# Study Of SU011248 In Patients With Metastatic Non-Small Cell Lung Cancer

> **NCT00092001** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 111 (actual)

## Conditions studied

- Carcinoma, Non-Small-Cell Lung

## Interventions

- **DRUG:** Sunitinib

## Key facts

- **NCT ID:** NCT00092001
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2007-03
- **Final completion:** 2007-03
- **Target enrollment:** 111 (ACTUAL)
- **Last updated:** 2008-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00092001

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00092001, "Study Of SU011248 In Patients With Metastatic Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00092001. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*